MYBL2 and cancer: As our previous study revealed that KIF2C is a key mitotic hub gene with diagnostic and therapeutic potential in cancers such as nasopharyngeal carcinoma 49, we then selected this B-Myb target gene to examine its functional implication in the most prominent and deadly cancer type, LUAD 18.